Recurring deviations, overdue CAPAs, and weak closure evidence often signal a broken CAPA process. Elexes identifies where your CAPA system fails and helps strengthen effectiveness before audits or inspections.
This service reviews CAPA effectiveness and remediation priorities. Full QMS implementation or enterprise-wide CAPA system rollout can be scoped separately.
Many CAPA systems appear compliant because records are technically closed. The real problem appears later.
Issues repeat. Investigations remain shallow. Similar CAPAs continue to reopen. Audit findings return despite corrective actions.
This creates a serious regulatory risk.
Under FDA and ISO 13485 expectations, CAPA effectiveness is not about closing records. It is about proving the issue will not recur.
When organizations cannot demonstrate CAPA effectiveness, regulators often view it as a broader quality system failure rather than an isolated issue.
Common warning signs include:
⦿ CAPAs repeatedly linked to the same complaint trends
⦿ Missing or weak root cause evidence
⦿ Actions implemented without verification
⦿ Closure approvals with no measurable effectiveness checks
⦿ Large CAPA backlogs with unclear prioritization
⦿ CAPAs disconnected from complaints, deviations, or audits
⦿ Quality Heads responsible for CAPA performance and audit readiness
⦿ Medical device manufacturers preparing for FDA inspections
⦿ Teams facing recurring nonconformities despite multiple CAPAs
⦿ Organizations preparing for ISO 13485 surveillance or recertification audits
⦿ SaMD, IVD, and hardware device manufacturers with aging CAPA backlogs
This service is not:
⦿ A generic QMS audit
⦿ A documentation-only review
⦿ Limited to CAPA SOP creation or templates
⦿ A one-time checklist exercise with no remediation guidance
⦿ A substitute for full QMS implementation support
Most CAPA systems fail for operational reasons, not because procedures are missing.
Organizations often have:
⦿ CAPA forms
⦿ SOPs
⦿ Closure workflows
⦿ Review meetings
But they still struggle with repeat issues and weak audit outcomes.
Elexes focuses on identifying why the CAPA process fails in practice.
We assess:
⦿ Root cause quality
⦿ Investigation depth
⦿ Effectiveness monitoring
⦿ Closure discipline
⦿ CAPA escalation logic
⦿ Trend linkage across complaints and deviations
The goal is simple:
Build a CAPA system that stands up to audits and reduces repeat quality issues.
We review:
⦿ CAPA records and workflows
⦿ CAPA aging and backlog trends
⦿ Escalation practices
⦿ Linkage with complaints, audits, deviations, and nonconformities
We evaluate:
⦿ Root cause investigation depth
⦿ Corrective action quality
⦿ Verification and validation evidence
⦿ Closure rationale
⦿ Repeat CAPA patterns
We help define:
⦿ Measurable effectiveness criteria
⦿ Risk-based escalation rules
⦿ Closure requirements
⦿ Monitoring expectations
⦿ CAPA prioritization logic
We support improvements to:
⦿ CAPA procedures
⦿ Investigation templates
⦿ Effectiveness review formats
⦿ Closure evidence documentation
Where needed, we support:
⦿ Remediation of weak or aging CAPAs
⦿ Closure evidence improvement
⦿ Monitoring framework implementation
⦿ CAPA governance improvements
The review aligns with:
⦿ FDA 21 CFR 820 CAPA expectations
⦿ ISO 13485:2016 requirements
⦿ EU MDR quality system expectations
At the end of the engagement, you receive:
⦿ CAPA Health Report
⦿ CAPA Effectiveness Framework
⦿ CAPA Remediation Roadmap
⦿ CAPA Closure Criteria Checklist
⦿ Root Cause Improvement Guide
⦿ CAPA Metrics Dashboard
⦿ CAPA Prioritization Recommendations
⦿ Audit Readiness Improvement Actions
CAPA is one of the most heavily reviewed subsystems during inspections and audits.
Weak CAPA systems often lead to:
⦿ FDA observations
⦿ Repeat audit findings
⦿ Delayed certifications
⦿ Increased regulatory scrutiny
⦿ Loss of confidence from notified bodies and customers
⦿ Product quality and patient safety risks
A recurring issue with ineffective CAPA is that regulators rarely view it as a single isolated gap. They often interpret it as evidence of broader quality system weakness.
⦿ Experience across FDA, EU MDR, and ISO 13485 systems
⦿ Expertise across SaMD, IVD, and hardware devices
⦿ Senior regulatory and quality expert involvement
⦿ Practical audit-readiness focus
⦿ Strong understanding of recurring CAPA failure patterns
⦿ Experience reviewing CAPA systems under active audit pressure
⦿ Remediation-focused approach rather than theory-only consulting
Device Type
Class II Diagnostic Device
Challenge
The company experienced recurring complaint-driven CAPAs despite repeated corrective actions.
Several CAPAs were technically closed, but effectiveness evidence remained weak.
Work Performed
Elexes:
⦿ Reviewed historical CAPA records
⦿ Evaluated investigation depth
⦿ Assessed effectiveness verification methods
⦿ Redesigned root cause and closure evaluation approach
Outcome
The organization improved:
⦿ CAPA closure consistency
⦿ Investigation quality
⦿ Audit readiness
⦿ Effectiveness evidence visibility
Recurring CAPAs and weak closure evidence rarely improve without structured review.
Elexes helps medical device companies identify why CAPA systems fail and what needs to change before audits or inspections expose the gaps.
CAPA is a quality system process used to investigate issues, identify root causes, implement corrective actions, and prevent recurrence.
CAPA is typically required when recurring problems, complaint trends, audit findings, deviations, or systemic quality issues are identified.
CAPA helps manufacturers reduce recurring failures, improve compliance, strengthen product quality, and support patient safety.
CAPA effectiveness is measured through objective evidence showing the issue has been resolved and does not recur over time.
Yes. The assessment can focus on specific CAPAs, complaint categories, audit findings, or high-risk areas.
Yes. The service helps identify CAPA weaknesses that auditors commonly review during inspections and surveillance audits.
Our process begins with an in-depth consultation where we learn about your medical device, its intended use, and your specific goals. This helps us tailor our assessment to your unique needs.
Our team of experts is well-versed in global medical device regulations, including FDA submissions, CE marking, TGA requirement, Health Canada approvals, ISO, and more. We stay up-to-date with the latest changes in the regulatory landscape.
We will conduct a comprehensive review of your existing documentation, including design files, clinical data, quality management systems, and risk assessments.
Our consultants will perform a gap analysis to identify any areas where your device may fall short of compliance. This forms the basis for our recommendations.
Based on our findings, we will provide you with detailed recommendations and a roadmap for achieving compliance. This may involve revising documentation, conducting additional testing, or making necessary design changes.
Our services don't stop with just the assessment. We offer ongoing support to guide you through the compliance process, helping you address any challenges that may arise.
Elexes offers a globally recognized ISO 13485 certification consultant who is renowned to enhancing your business credibility in the medical devices industry.
Our presence across the globe ensures audits are conducted by local-language auditors, facilitating clear communication and understanding.
Our experts provide guidance and consultants to help you adhere to necessary regulations, ensuring your products meet all legal requirements and is compliant to all necessary standards.
At Elexes, we offer to assist in securing additional local certifications, enabling you to manufacture and sell medical devices in various markets across the globe.
We offer complete confidentiality to all our clients which makes us one of the most trusted regulatory and quality compliance consulting.
We offer different services that will help you not only keep your product well in boundaries of regulations but also speed up the entire approval process. Some of these services are -
CEO Masterlink, Arizona
CEO Novasignal, Los Angeles
President ViDava, Florida
Sr. Exe Treedental, Hong Kong
Manager Outset Medical, California
CTO Jana Care, Massachusetts
MD Blackrock Pharma, England
VP Regulatory AliveCor, California
Owner Liz Inc., Arizona
CEO Radformation, New York
Never miss out on any important update on the regulatory & compliance industry across the globe. Subscribe to our newsletter now.
Copyright 2025, Elexes Medical Consulting Pvt. Ltd. All Rights Reserved
Working Hours : Monday to Friday 9:00 AM - 7:00 PM
Team Elexes 
